logo

Madrigal Pharmaceuticals Inc (MDGL) Stock: Navigating Drops and Gains

Examining a stock’s 52-week price history, encompassing its low and high prices, can reveal much about its existing condition and potential future trajectory. Madrigal Pharmaceuticals Inc’s current trading price is -25.57% away from its 52-week high, while its distance from the 52-week low is 62.93%. The stock’s price range over this period has fluctuated between $168.25 and $368.29. The company, operating within the financial sector, had a trading volume of approximately 0.57 million for the day, which was noticeably higher than the average daily share volume of 0.43 million over the last 3 months.

In terms of market performance, Madrigal Pharmaceuticals Inc had a fairly even. The highest value for the stock in the past year was $368.29 on 11/07/24, and the lowest value was recorded at $168.25 on 02/09/24.

Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis

Madrigal Pharmaceuticals Inc (MDGL) has experienced a quarterly rise of 28.00% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 5.98B and boasts a workforce of 376 employees.

Analyzing Trading Volume and Moving Average Trends

Based on Barchart.com data, the company’s moving average over the 100-day period was 271.78, with a change in price of +14.95. Similarly, Madrigal Pharmaceuticals Inc recorded 366,395 in trading volume during the last 100 days, posting a change of +5.77%.

Understanding Ticker ‘s Debt-to-Equity Ratio: An Analysis

The debt-to-equity (D/E) ratio serves as an important indicator of a company’s financial stability and market position. By dividing a company’s total liabilities by its shareholders’ equity, the D/E ratio reveals the degree to which a company relies on debt to finance assets compared to its shareholders’ equity. At the time of writing, the total D/E ratio for MDGL stands at 0.15. Similarly, the long-term debt-to-equity ratio is also 0.15.

MDGL Stock Stochastic Average

Today, Madrigal Pharmaceuticals Inc’s raw stochastic average for the past 50 days stands at 27.70%, indicating a rise from the raw stochastic average of the last 20 days, which was 0.39%. Moreover, the company’s Stochastic %K and %D values over the past 20 days were 41.78% and 68.63% respectively.

MDGL Stock Price Performance Analysis

A mixed performance in the stock price over the year has left investors unsure of what to expect, resulting in a range of outlooks from optimistic to pessimistic. Until today this year the stock’s price performance recorded a decrease of -11.16%. However, over the last six months, the performance has been stronger by -2.08%. The price of MDGL decreased -10.58% over the last 30 days. And in the last five days, it has fallen by -14.55%.

Most Popular